It was a tough day for Theratechnologies Inc. (TH:CA) as its stock fell 12.68% to finish the day at $4.82 a share on October 08. That reduces the company’s market cap to 370.92 million on 76.95 million outstanding shares. Theratechnologies Inc. is a component of the the S&P/TSX SmallCap Index.
278,947 shares exchanged hands over the course of the day as compared with an average daily volume of n/a over the last 30 days.
Theratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. The firm mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.. Theratechnologies Inc. makes its home in Montreal, QC, and currently has CEO Luc Tanguay at the helm.
The past 52 weeks have seen the stock trade in a range between a high of $9.74 and a low of $4.86, and it’s currently sporting a 50-day SMA of $n/a and a 200-day SMA of $n/a. The current P/E ratio stands at n/a, with a P/B ratio of 8.93.
Theratechnologies Inc. ($TH:CA) is one of the 200 Canadian small-cap stocks that make up the S&P500/TSX SmallCap Index, the widely recognized benchmark for gauging the performance of the Canadian small-cap market. Similar to the Russell 2000 in the United States, the index is market cap-weighted and consists only of smaller companies. To be a part of the index, a company must have a market capitalization between C$100 million and C$1.5 billion with an average share price of C$1 or more.
